Final day at #ESGCT2026 in Hamburg 🇩🇪!

We're still at the BSGCT stand if you'd like to chat about grants, awards, the Society and our mentorship scheme.

Applications for the mentorship scheme close on 30 November 2026.

Follow us on Instagram (@bsgct) for more day-to-day conference coverage.

📌Last day at #ESGCT2026
🎤Barry Byrne will present encouraging Phase 1 results of ATA-200 for #LGMDR5.
🎤 Arnaud Valent will share updated clinical data from the GNT0004 Duchenne muscular dystrophy trial.
Advancing gene therapy from science to patients.

#GeneTherapy #DMD #ClinicalTrials #Genethon

📢 Busy day for @genethonfr.bsky.social at #ESGCT2026!
🎤 Tiziana La Bella will present next-generation enzymes designed to eliminate neutralising antibodies and support repeat dosing in gene therapy.
📌 13 posters will also showcase advances in #GeneEditingGene, #AAVengineering, #immunology

BSGCT is at ESGCT 2026 in Hamburg from 27 to 30 October! Come say hi at the BSGCT stand and chat to Ouidad Khechaoui, Emily Bates and the team to learn more about Society membership, grants, awards, mentoring schemes and more.

#ESGCT2026 #BSGCT #CellAndGeneTherapy #Hamburg

📌 Poster Day at #ESGCT2026
Meet @genethonfr.bsky.social R scientists and discover 8 projects covering:
🧬 #AAV engineering, immune evasion, Duchenne muscular dystrophy, clinical research, next-generation vectors.

From GNT0003 to Optidys, join the discussion!

#GeneTherapy #DMD #RareDiseases

#ESGCT2026 opens today!
💡 Isabelle Richard co-chairs the session on AAV & non-integrative vectors.
🎤 Giuseppe Ronzitti will address immune responses to AAVs and prospects for redosing.
🎤 Adrian Westhaus will present next-generation AAV vectors designed to evade pre-existing antibodies.

J-7 avant #ESGCT2026 à Hambourg !
Les équipes de
@genethonfr.bsky.social r
présenteront leurs dernières avancées :
🔬 5 communications orales
📌 21 posters scientifiques
🤝 2 sessions coprésidées

👉 urlr.me/33RE7Z
@ESGCT

#ThérapieGénique #MaladiesRares #Recherche

One week to go until #ESGCT2026 in Hamburg!
@genethonfr.bsky.social r
will share its latest advances with the gene &cell therapy community:
🔬 5 oral presentations
📌 21 posters
🤝 2 co-chaired sessions

👉https://urlr.me/33RE7Z

#GeneTherapy #RareDiseases #AAV

We're excited for #ESGCT2026! There’s a few ways to see us:

🧬Join IDT at booth #C-03 to see how we’re advancing the future of cell and gene therapy through precision genome editing.
🪧Visit our poster presentation on multiplexed empirical off-target nomination.

https://www.esgctcongress.com/

We’re heading to #ESGCT2026 in Hamburg - and we’d love to see you there! Stop by 𝗕𝗼𝗼𝘁𝗵 𝗛𝟬-𝟳 to meet the Novogene Europe team, have a chat about your research.

📅 𝟮𝟳–𝟯𝟬 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟬𝟮𝟲
📍 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗖𝗲𝗻𝘁𝗲𝗿 𝗛𝗮𝗺𝗯𝘂𝗿𝗴
📌 𝗕𝗼𝗼𝘁𝗵 𝗛𝟬-𝟳